| Field | Specification |
|---|---|
| Target | |
| Alternative names | TGF-β1 |
| Species | |
| Applications | |
| Tag | |
| Expression system | |
| Expression region | |
| Molecular weight | |
| Purity | |
| Biological activity | |
| Endotoxin level | |
| Animal origin-free | |
| Reconstitution | |
| Formulation | |
| Form | Lyophilized |
| Storage | |
| Catalog no. (Mfr.) | |
| Main SKU |
Product Overview
Recombinant Human TGF beta1 Protein (TGF-β1) is the mature, non-glycosylated homodimer expressed in human cells. It is manufactured in an animal-free, xeno-free and tag-free format and supplied lyophilized without carrier protein, at >95% purity by SDS-PAGE and endotoxin <0.5 EU/µg.
TGF-β1 is used to study regulatory T-cell differentiation, tolerance and immune suppression, fibroblast activation and matrix deposition, epithelial–mesenchymal transition (EMT) and TGFBR–SMAD2/3 signaling. Activity is confirmed in a cell-based HT-2 assay, and two peer-reviewed studies report the use of this TGF-β1.
Expression system: Human cells · Tag-free · Animal-free
Scientific Background
TGF-β1 is the most abundant TGF-β isoform in mammals and is secreted as part of a latent complex that must be activated before it can signal. The active homodimer binds TGFBR2, which recruits and activates TGFBR1/ALK5. This leads to phosphorylation of SMAD2 and SMAD3, which partner with SMAD4 to regulate transcription.
TGF-β1 also engages non-SMAD pathways, including MAPK and PI3K, and its effects depend on cell identity and microenvironment. It is studied in immune tolerance, regulatory T-cell biology, fibrosis, EMT, extracellular-matrix regulation, myogenesis and stem/progenitor differentiation.
Research Applications
TGF-β1 is used where SMAD2/3 signaling drives immune regulation, matrix programs or epithelial plasticity. The table summarizes typical workflow placement; it is a planning guide, not a universal protocol.
| Application | Role of TGF-β1 | Companion signals and context | Suggested readouts |
|---|---|---|---|
| Regulatory T-cell differentiation | TGF-β-dependent FOXP3 induction | IL-2 and TCR stimulation | FOXP3, CD25, suppressive function |
| Fibroblast activation | Drives the myofibroblast and matrix program | Defined serum context | α-SMA, COL1A1, fibronectin and contraction |
| EMT model | Induces epithelial plasticity | Time course and pathway inhibitors | E-cadherin, vimentin, migration |
| SMAD signaling assay | Acute receptor activation | ALK5 inhibitor control | pSMAD2/3, nuclear translocation, target genes |
Planning considerations
- Define the responsive cell stage and confirm that the cells express the relevant receptors.
- Begin with a validated protocol, then run a dose response for the actual cell source, medium and endpoint.
- Control timing and companion factors, since signal order and duration can change lineage or functional outcomes; include no-factor, vehicle and pathway-response controls.
- Measure phenotype and function rather than cell number alone. No EC50 or universal working concentration applies without lot- or protocol-specific evidence.
Protein Specifications
| Target | TGF beta1 (also known as TGF-β1) |
|---|---|
| Alternative names | TGF-β1 |
| Species | Human |
| Expression system | Human cells |
| Structure | Non-glycosylated homodimer |
| Protein family | TGF-β superfamily |
| Expression region | Full length |
| Tag | Tag-free |
| Animal origin | Animal-free / xeno-free |
| Molecular weight | 25 kDa. Refer to the lot-specific Certificate of Analysis (CoA) for lot data. |
| Purity | >95% by SDS-PAGE |
| Endotoxin level | <0.5 EU/µg |
| Formulation | Lyophilized from a 0.2 µm-filtered solution in 10 mM sodium acetate without carrier protein |
| Form | Lyophilized |
| Biological activity | Inhibition of IL-4-induced proliferation in mouse HT-2 cells |
| Applications | Stem Cell Differentiation, Immunotherapy, Cell Signaling Studies, Epithelial-Mesenchymal Transition |
Biological Activity & Quality Control
Biological activity is evaluated by the ability of TGF-β1 to inhibit IL-4-induced proliferation of mouse HT-2 cells.
Lot-specific activity and purity data are provided on the Certificate of Analysis (CoA), available from BioHippo on request.
Reconstitution
- Briefly centrifuge the vial before opening.
- Reconstitute in sterile 4 mM HCl containing at least 0.1% human or bovine serum albumin.
- Avoid repeated freeze–thaw cycles.
Storage & Shipping
| Storage | As supplied: −20°C to −80°C for up to 12 months from receipt. After reconstitution: 2°C to 8°C for up to 1 month, or −20°C to −80°C for up to 3 months, under sterile conditions. Avoid repeated freeze–thaw cycles. |
|---|---|
| Shipping | Please contact us to confirm shipping conditions for this product. |
Selected References
- Massagué J (2012) TGFβ signalling in context. Nat Rev Mol Cell Biol 13:616-630. 10.1038/nrm3434
- Oshimori N, Fuchs E (2012) The harmonies played by TGF-β in stem cell biology. Cell Stem Cell 11:751-764. 10.1016/j.stem.2012.11.001
Safety & Handling
Handle as a laboratory reagent and consult the linked SDS before use. Avoid repeated freeze–thaw cycles of the reconstituted protein.
For research use only. Not for diagnostic or therapeutic use.
Can't Find What You're Looking For? We can help you source the best match or customize a recombinant protein solution for your study. Options may include species (human/mouse/rat), protein region/domain (full-length vs fragment), tag or label (His/GST/FLAG/biotin/fluorescent), expression system (E. coli/HEK293/insect), purity grade, formulation (buffer, carrier-free, glycerol-free), activity/functional validation (binding or enzymatic assays), endotoxin level (low-endotoxin for cell-based work), mutants/variants (point mutations, isoforms), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Jing Y, et al. (2023) Single-nucleus profiling unveils a geroprotective role of the FOXO3 in primate skeletal muscle aging. Protein Cell 14:497-512. 10.1093/procel/pwac061
Yan P, et al. (2020) Genome-wide R-loop Landscapes during Cell Differentiation and Reprogramming. Cell Rep 32:107870. 10.1016/j.celrep.2020.107870